Skip to main content

Y-mAbs Therapeutics, Inc.

YMABDelisted Sep 16, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001722964

Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Y-mAbs Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of YMAB: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders91100+9
Shares24.8M23.6M−1.20M (−4.9%)
Value$374.7M$339.7M−$34.9M (−9.3%)

New holders (16)

Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to YMAB in Q3 2022
InstitutionSharesValue% of portfolio
Driehaus Capital Management LLC297,252$4.29M0.06%
Citadel Advisors LLC90,460$1.30M0.00%
UBS Oconnor LLC44,000$634.0K0.01%
Victory Capital Management Inc32,990$476.0K0.00%
Qube Research & Technologies Ltd28,251$407.0K0.00%
Walleye Trading LLC26,607$384.0K0.01%
Marshall Wace, LLP20,470$295.0K0.00%
Trexquant Investment LP15,912$229.0K0.01%
Jane Street Group, LLC12,375$178.0K0.00%
Teacher Retirement System of Texas10,807$156.0K0.00%
Man Group plc10,300$149.0K0.00%
Aquatic Capital Management LLC7,500$108.0K0.01%
Advisor Group Holdings, Inc.1,683$24.0K0.00%
Russell Investments Group, Ltd.816$11.0K0.00%
China Universal Asset Management Co., Ltd.410$6.00K0.00%
Signaturefd, LLC15$00.00%

Sold out (7)

Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of YMAB in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Allianz Asset Management GmbH32,085$485.0K
HRT Financial LP31,678$479.0K
Ergoteles LLC28,697$434.0K
Balyasny Asset Management LLC14,122$214.0K
DnB Asset Management AS13,399$202.7K
Lazard Asset Management LLC5,655$85.0K
Captrust Financial Advisors154$2.00K